StrategyTransparency Bills May Have Unintended Consequences
Lawmakers hear concerns about provisions on drug samples, price increases.
FinanceKroger Health President Talks 'Food as Medicine,' Prescription Drug Prices
Colleen Lindholz, president of Kroger Health, spoke about the grocery store's plans to expand further into healthcare.
StrategyBig Pharma Gave Money To Patient Advocacy Groups Opposing Medicare Changes
KHN's Pre$cription for Power database now includes nearly 14,000 transactions, totaling $163 million in donations from 26 drugmakers to 650...
Finance4 Takeaways From Pharma Testimony at Senate Drug Pricing Hearing
Major industry leaders defended themselves against accusations of immoral price hikes, telling senators that they intend to provide patients with...
FinanceHHS Proposal Could Kill PBM Rebates: Some Pleased, Others Concerned
The proposal would end safe-harbor protections for the rebates drug manufacturers pay to PBMs and add safe-harbor protections for drug...
StrategyWalgreens-Microsoft Alliance Puts More Pressure on Hospitals
The drugstore chain's partnership with Microsoft is designed to close existing gaps in care in the traditional healthcare system, says...
FinanceSecretive 'Rebate Trap' Keeps Generic Drugs For Diabetes And Other Ills Out Of Reach
Drug companies routinely make hidden pacts with middlemen that effectively block patients from getting cheaper generic medicines.
FinanceAzar Defends Plan to Lower Part B Drug Costs
Drugmakers aren't just going to walk away from Medicare, he says.
Clinical CareTop Cancer Doctor, Forced Out Over Ties to Drug Makers, Joins Their Ranks
AstraZeneca has hired Dr. José Baselga, the former chief medical officer at Memorial Sloan Kettering, to lead its cancer research...
FinanceWhy The U.S. Remains The World's Most Expensive Market For 'Biologic' Drugs
Biologic drugs, made from living organisms, are big moneymakers partly because they have little competition from 'biosimilars.' It's a very...
StrategyCigna–Express Scripts Secures Final Regulatory Approval
The $71 billion deal, which joins a major insurer with a PBM, is expected to close Thursday.
Clinical CareProminent Doctors Aren't Disclosing Their Industry Ties in Medical Journal Studies. And Journals Are Doing Little to Enforce Their Rules
The dean of Yale's medical school, the incoming president of a prominent cancer group and the head of a Texas...